177 related articles for article (PubMed ID: 24377644)
1. Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment.
Thunyaharn N; Promthet S; Wiangnon S; Suwanrungruang K; Kamsa-ard S
Asian Pac J Cancer Prev; 2013; 14(11):7029-32. PubMed ID: 24377644
[TBL] [Abstract][Full Text] [Related]
2. Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
Pattanathien P; Khuntikeo N; Promthet S; Kamsa-Ard S
Asian Pac J Cancer Prev; 2013; 14(1):321-4. PubMed ID: 23534746
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand.
Woradet S; Promthet S; Songserm N; Parkin DM
Asian Pac J Cancer Prev; 2013; 14(3):1623-7. PubMed ID: 23679246
[TBL] [Abstract][Full Text] [Related]
4. Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
Sriputtha S; Khuntikeo N; Promthet S; Kamsa-Ard S
Asian Pac J Cancer Prev; 2013; 14(2):1107-10. PubMed ID: 23621195
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases from cholangiocarcinoma: a first case series in Thailand.
Chindaprasirt J; Sookprasert A; Sawanyawisuth K; Limpawattana P; Tiamkao S
Asian Pac J Cancer Prev; 2012; 13(5):1995-7. PubMed ID: 22901160
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic cholangiocarcinoma in Thailand.
Uttaravichien T; Bhudhisawasdi V; Pairojkul C; Pugkhem A
J Hepatobiliary Pancreat Surg; 1999; 6(2):128-35. PubMed ID: 10398899
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
Kaneko R; Sato Y; Kobayashi Y
J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
[TBL] [Abstract][Full Text] [Related]
9. Identification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinoma.
Zhang GW; Lin JH; Qian JP; Zhou J
Ann Surg Oncol; 2014 Oct; 21(11):3628-37. PubMed ID: 24781504
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study.
Luvira V; Nilprapha K; Bhudhisawasdi V; Pugkhem A; Chamadol N; Kamsa-ard S
Asian Pac J Cancer Prev; 2016; 17(1):401-6. PubMed ID: 26838246
[TBL] [Abstract][Full Text] [Related]
11. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
12. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
13. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
14. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
[TBL] [Abstract][Full Text] [Related]
15. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
[TBL] [Abstract][Full Text] [Related]
17. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
[TBL] [Abstract][Full Text] [Related]
18. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
[TBL] [Abstract][Full Text] [Related]
19. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
[No Abstract] [Full Text] [Related]
20. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.
Cheon YK; Lee TY; Lee SM; Yoon JY; Shim CS
HPB (Oxford); 2012 Mar; 14(3):185-93. PubMed ID: 22321037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
